Drug profile · INN
palopegteriparatide
YORVIPATH
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
palopegteriparatide (YORVIPATH) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN palopegteriparatide
Brand YORVIPATH
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code H05AA
Frequently asked questions
What is palopegteriparatide?
palopegteriparatide (YORVIPATH) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for palopegteriparatide?
YORVIPATH is a marketed brand name for palopegteriparatide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of palopegteriparatide?
palopegteriparatide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.